Editorial: serum HBV RNA biphasic decline in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues-authors' reply

Aliment Pharmacol Ther. 2020 Sep;52(5):883-884. doi: 10.1111/apt.15993.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens*
  • Hepatitis B virus / genetics
  • Hepatitis B, Chronic* / drug therapy
  • Humans
  • Kinetics
  • Nucleosides / therapeutic use
  • RNA

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Nucleosides
  • RNA